Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/15/01 → 12/31/08 |
Funding
- Merck and Company Inc: $111,151.00
Protocol 008-01 Study to Evaluate the Safety, Tolerability & Immunogenicity of the HIV-1 Gag DNA Vaccine Formulated with PBS or with Aluminum Phosphage Followed by AD5 HIV-1 Gag Vaccine in a Prime Boost Regimen
- Greenberg, Richard (PI)
- Pomeroy, Claire (CoI)